Braf-mutant Cancers

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-10-21
Clinical Trial Update: A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers [Phase 1, Phase 2]
A phase 1/phase 2 study evaluating the combination of binimetinib and encorafenib in advanced BRAF-mutant cancers has completed and posted r…